MedCity News January 11, 2021
Biogen plans to launch a virtual study with Apple this year to identify early signs of mild cognitive impairment. The study is expected to launch in the second half of 2021.
Biogen and Apple plan to launch a virtual study to identify early signs of decline in cognitive health. The goal is to see how devices, such an Apple Watch of iPhone, could be used to monitor cognitive performance over time and identify early signs of mild cognitive impairment, which is estimated to affect 15% to 20% of adults over age 65.
The multi-year, observational study is expected to launch in the second half of 2021, including both young and older adults with a range of cognitive performance. Biogen and...
Today's Sponsors
Today's Sponsor